1676
|
BXL 628
|
Vitamin D receptor (VDR) agonist |
€150.00 |
1130
|
BX 912
|
PDPK1 inhibitor |
€80.00 |
3350
|
BX 795 hydrochloride
|
PDPK1, TBK1 and IKK inhibitor |
€80.00 |
1390
|
BX 795
|
PDPK1, TBK1 and IKK inhibitor |
€60.00 |
2082
|
BX 471
|
Selective CCR1 receptor antagonist |
€105.00 |
2523
|
BX 430
|
Allosteric antagonist of human P2X4 receptor channels |
€105.00 |
1756
|
BVT 2733 hydrochloride
|
Inhibitor of 11β-hydroxysteroid dehydrogenase type 1 |
€90.00 |
3508
|
Butoconazole nitrate
|
Potent antifungal agent |
€70.00 |
3380
|
Butenafine hydrochloride
|
Broad-spectrum antifungal agent |
€50.00 |
1228
|
Butabindide oxalate
|
TPP2 inhibitor |
€110.00 |
1995
|
Buspirone hydrochloride
|
5-HT1A partial agonist |
€50.00 |
1451
|
Bupropion hydrochloride
|
DRI and NRI; nicotinic acetylcholine receptor antagonist |
€85.00 |
1969
|
Buloxibutid
|
First non-peptide selective AT2 receptor agonist |
Inquire |
2698
|
BTZ043
|
Antimycobacterial DprE1 inhibitor that kills Mycobacterium tuberculosis |
€105.00 |
3481
|
BTYNB isomer
|
Ring-closed isomer of BTYNB |
€110.00 |
3437
|
BTYNB
|
Potent and selective IMP1 inhibitor |
€90.00 |
3431
|
BTSA1
|
Potent activator of proapoptotic BAX |
€110.00 |
1257
|
BTS 54-505
|
5-HT uptake inhibitor |
€85.00 |
2407
|
BTB 1
|
The first small molecule reversible inhibitor of the mitotic motor protein Kif18A |
€70.00 |
2334
|
BT2
|
Allosteric inhibitor of BCKDC kinase (BDK) and Mcl-1 inhibitor |
€95.00 |
2749
|
BT-11
|
First-in-class, orally active LANCL2 binding compound |
€110.00 |
2804
|
Broxaldine
|
Antiprotozoal drug |
€65.00 |
1157
|
Bromobuterol
|
β2 agonist |
€85.00 |
3664
|
Brivudine
|
Inhibitor of herpes virus DNA polymerase |
€90.00 |
1864
|
Brivanib alaninate
|
Prodrug of BMS 540215; Inhibitor of VEGF |
€90.00 |
3988
|
Brinzolamide
|
Potent carbonic anhydrase inhibitor |
€70.00 |
1555
|
Brimonidine tartrate
|
α2 adrenoceptor agonist |
€70.00 |
2978
|
Brigatinib
|
Potent, selective, and orally active anaplastic lymphoma kinase (ALK) inhibitor |
€80.00 |
2335
|
Brexpiprazole dihydrochloride
|
Drug candidate with high affinity for 5-HT1A, 5-HT2A, D2L, α1B, and α2C-adrenergic receptors |
€135.00 |
3153
|
BRD5648
|
Negative control compound of BRD0705 as a GSK3α inhibitor |
€180.00 |